Clarify Health Solutions, Inc., a provider of real-time care guidance technology, announced that it has closed $57 million in a Series B financing round led by KKR, a global investment firm. Building upon the Company’s rapid customer expansion in 2018, the injection of new capital will fuel the Company’s growth on its mission to power the personalization and optimization of every care journey.

Clarify brings hospital, health insurance, and life sciences customers the latest financial services and consumer technologies coupled with the deep clinical expertise needed to power innovative care delivery models. Clarify’s solutions deploy predictive analytics and machine learning on a comprehensive data set of over 20 terabytes – representing clinical, claims, social determinant, laboratory, and prescription data – to provide actionable insights and automate care navigation. The Company’s Care Journey Platform enables doctors to gain the confidence of matching patients to the most appropriate care, while patients benefit from real-time visibility and guidance.
Clarify plans to use the new funding to expand its clinical transformation, sales, engineering, and data science teams, to acquire new data assets, and to accelerate the development of its digital care guidance platform. This will help widen Clarify’s reach in supporting customers in their delivery of more effective and delightful care to patients nationwide.

“We are thrilled to partner with KKR to build the world’s first real-time care guidance platform,” said Jean Drouin, MD, CEO and Co-Founder, Clarify Health Solutions. “We are entering a new era, where technology can help us to reimagine care delivery. We have accepted for far too long that an accessible, service-oriented, and customer-centric experience is simply unattainable in health care. We are committed to making the words ‘delightful,’ ‘healed,’ and ‘affordable’ far more common in the health care lexicon.”

For KKR, the investment is being funded through the firm’s Health Care Strategic Growth Fund, which is focused on investing in high-growth health care-related companies for which KKR can be a unique partner in helping reach scale.

“Today’s health care market is not only very complicated but also extremely fragmented and marked by patient dissatisfaction,” said Ali Satvat, Member of KKR and Head of KKR’s Health Care Strategic Growth investing efforts.

“The impressive and highly experienced team at Clarify is addressing this problem by bringing the power of technology to the industry in a way in which it has not been applied to date. We are delighted to partner with Clarify on this effort to enable a more effective, efficient, and simply better health care experience for both physicians and the patients who need it.”